The FIRCE-1 trial investigating the CAR T-cell therapy firi-cel in relapsed/refractory large B-cell lymphoma has been ...
The prognosis of patients with gastrointestinal stromal tumors is significantly impacted by gastrointestinal bleeding.
Slowing down is linked to physiological changes, including reduced energy transformation in muscle cells and sluggish red ...
Dr. Ritu Salani discusses how patients with cervical cancer can advocate for their health and collaborate with their medical team to ensure the best care.
Dr. Debu Tripathy discusses the FDA approval of Enhertu in unresectable or metastatic hormone receptor HR+, HER2-low or -ultralow breast cancer.
Dr. Tycel Phillips discusses the implications of the FDA approval of Calquence plus bendamustine and Rituxan in untreated MCL ...
The FDA has updated the product labeling for Xeloda and 5-FU to highlight the risks associated with dihydropyrimidine ...
Throughout my experience with multiple myeloma, I was humbled by the unexpected support and kindness shown to me.
THIO sequenced with Libtayo extended overall survival in those with non–small cell lung cancer who progressed on two or more ...
The Decipher Bladder Genomic Subtyping Classifier found that patients with luminal tumors may have less aggressive disease.
Dr. Suneel Kamath discusses the ALASCCA study in colorectal cancer and highlighted the importance of next-generation sequencing and testing.
In a clinical trial, patients treated with a kidney cancer vaccine remained cancer-free after a median of nearly three years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback